Click for best price
Migraine Drugs Market Size, Share 2022
Market Analysis and Insights: Global Migraine Drugs Market
The global Migraine Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Migraine Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Migraine Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Migraine Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Migraine Drugs market.
Global Migraine Drugs Scope and Market Size
Migraine Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Migraine Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Sumatriptan
Zolmitriptan
Rizatriptan
Others Drug
Segment by Application
Hospitals
Clinics
Household Use
Others
By Company
Allergan
Merck
Pfizer
Teva
Pfizer
Johnson & Johnson
Endo International
GlaxoSmithKline
Impax
Abbott
Bayer
Eli Lilly
Ethypharm
Kowa Pharmaceuticals America
Winston Pharmaceuticals
AstraZeneca
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Migraine Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Migraine Drugs, with price, sales, revenue, and global market share of Migraine Drugs from 2019 to 2022.
Chapter 3, the Migraine Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Migraine Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Migraine Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Migraine Drugs.
Chapter 13, 14, and 15, to describe Migraine Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Migraine Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Migraine Drugs Market Insights, Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
111 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Migraine Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Migraine Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Sumatriptan
1.2.3 Zolmitriptan
1.2.4 Rizatriptan
1.2.5 Others Drug
1.3 Market by Application
1.3.1 Global Migraine Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Household Use
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Migraine Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Migraine Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Migraine Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Migraine Drugs Sales by Region
2.4.1 Global Migraine Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Migraine Drugs by Region (2023-2028)
2.5 Global Migraine Drugs Revenue by Region
2.5.1 Global Migraine Drugs Revenue by Region (2017-2022)
2.5.2 Global Migraine Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Migraine Drugs Sales by Manufacturers
3.1.1 Global Top Migraine Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Migraine Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Migraine Drugs in 2021
3.2 Global Migraine Drugs Revenue by Manufacturers
3.2.1 Global Migraine Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Migraine Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Migraine Drugs Revenue in 2021
3.3 Global Migraine Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Migraine Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Migraine Drugs Sales by Type
4.1.1 Global Migraine Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Migraine Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Migraine Drugs Sales Market Share by Type (2017-2028)
4.2 Global Migraine Drugs Revenue by Type
4.2.1 Global Migraine Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Migraine Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Migraine Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Migraine Drugs Price by Type
4.3.1 Global Migraine Drugs Price by Type (2017-2022)
4.3.2 Global Migraine Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Migraine Drugs Sales by Application
5.1.1 Global Migraine Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Migraine Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Migraine Drugs Sales Market Share by Application (2017-2028)
5.2 Global Migraine Drugs Revenue by Application
5.2.1 Global Migraine Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Migraine Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Migraine Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Migraine Drugs Price by Application
5.3.1 Global Migraine Drugs Price by Application (2017-2022)
5.3.2 Global Migraine Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Migraine Drugs Market Size by Type
6.1.1 North America Migraine Drugs Sales by Type (2017-2028)
6.1.2 North America Migraine Drugs Revenue by Type (2017-2028)
6.2 North America Migraine Drugs Market Size by Application
6.2.1 North America Migraine Drugs Sales by Application (2017-2028)
6.2.2 North America Migraine Drugs Revenue by Application (2017-2028)
6.3 North America Migraine Drugs Market Size by Country
6.3.1 North America Migraine Drugs Sales by Country (2017-2028)
6.3.2 North America Migraine Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Migraine Drugs Market Size by Type
7.1.1 Europe Migraine Drugs Sales by Type (2017-2028)
7.1.2 Europe Migraine Drugs Revenue by Type (2017-2028)
7.2 Europe Migraine Drugs Market Size by Application
7.2.1 Europe Migraine Drugs Sales by Application (2017-2028)
7.2.2 Europe Migraine Drugs Revenue by Application (2017-2028)
7.3 Europe Migraine Drugs Market Size by Country
7.3.1 Europe Migraine Drugs Sales by Country (2017-2028)
7.3.2 Europe Migraine Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Migraine Drugs Market Size by Type
8.1.1 Asia Pacific Migraine Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Migraine Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Migraine Drugs Market Size by Application
8.2.1 Asia Pacific Migraine Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Migraine Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Migraine Drugs Market Size by Region
8.3.1 Asia Pacific Migraine Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Migraine Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Migraine Drugs Market Size by Type
9.1.1 Latin America Migraine Drugs Sales by Type (2017-2028)
9.1.2 Latin America Migraine Drugs Revenue by Type (2017-2028)
9.2 Latin America Migraine Drugs Market Size by Application
9.2.1 Latin America Migraine Drugs Sales by Application (2017-2028)
9.2.2 Latin America Migraine Drugs Revenue by Application (2017-2028)
9.3 Latin America Migraine Drugs Market Size by Country
9.3.1 Latin America Migraine Drugs Sales by Country (2017-2028)
9.3.2 Latin America Migraine Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Migraine Drugs Market Size by Type
10.1.1 Middle East and Africa Migraine Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Migraine Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Migraine Drugs Market Size by Application
10.2.1 Middle East and Africa Migraine Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Migraine Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Migraine Drugs Market Size by Country
10.3.1 Middle East and Africa Migraine Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Migraine Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Overview
11.1.3 Allergan Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Allergan Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pfizer Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Teva
11.4.1 Teva Corporation Information
11.4.2 Teva Overview
11.4.3 Teva Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Teva Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Teva Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Overview
11.6.3 Johnson & Johnson Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Johnson & Johnson Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson & Johnson Recent Developments
11.7 Endo International
11.7.1 Endo International Corporation Information
11.7.2 Endo International Overview
11.7.3 Endo International Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Endo International Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Endo International Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Corporation Information
11.8.2 GlaxoSmithKline Overview
11.8.3 GlaxoSmithKline Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 GlaxoSmithKline Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 GlaxoSmithKline Recent Developments
11.9 Impax
11.9.1 Impax Corporation Information
11.9.2 Impax Overview
11.9.3 Impax Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Impax Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Impax Recent Developments
11.10 Abbott
11.10.1 Abbott Corporation Information
11.10.2 Abbott Overview
11.10.3 Abbott Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Abbott Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Abbott Recent Developments
11.11 Bayer
11.11.1 Bayer Corporation Information
11.11.2 Bayer Overview
11.11.3 Bayer Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Bayer Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Bayer Recent Developments
11.12 Eli Lilly
11.12.1 Eli Lilly Corporation Information
11.12.2 Eli Lilly Overview
11.12.3 Eli Lilly Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Eli Lilly Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Eli Lilly Recent Developments
11.13 Ethypharm
11.13.1 Ethypharm Corporation Information
11.13.2 Ethypharm Overview
11.13.3 Ethypharm Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Ethypharm Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Ethypharm Recent Developments
11.14 Kowa Pharmaceuticals America
11.14.1 Kowa Pharmaceuticals America Corporation Information
11.14.2 Kowa Pharmaceuticals America Overview
11.14.3 Kowa Pharmaceuticals America Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Kowa Pharmaceuticals America Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Kowa Pharmaceuticals America Recent Developments
11.15 Winston Pharmaceuticals
11.15.1 Winston Pharmaceuticals Corporation Information
11.15.2 Winston Pharmaceuticals Overview
11.15.3 Winston Pharmaceuticals Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Winston Pharmaceuticals Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Winston Pharmaceuticals Recent Developments
11.16 AstraZeneca
11.16.1 AstraZeneca Corporation Information
11.16.2 AstraZeneca Overview
11.16.3 AstraZeneca Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 AstraZeneca Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 AstraZeneca Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Migraine Drugs Industry Chain Analysis
12.2 Migraine Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Migraine Drugs Production Mode & Process
12.4 Migraine Drugs Sales and Marketing
12.4.1 Migraine Drugs Sales Channels
12.4.2 Migraine Drugs Distributors
12.5 Migraine Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Migraine Drugs Industry Trends
13.2 Migraine Drugs Market Drivers
13.3 Migraine Drugs Market Challenges
13.4 Migraine Drugs Market Restraints
14 Key Findings in The Global Migraine Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Migraine Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Sumatriptan
Table 3. Major Manufacturers of Zolmitriptan
Table 4. Major Manufacturers of Rizatriptan
Table 5. Major Manufacturers of Others Drug
Table 6. Global Migraine Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Migraine Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Migraine Drugs Sales by Region (2017-2022) & (K Pcs)
Table 9. Global Migraine Drugs Sales Market Share by Region (2017-2022)
Table 10. Global Migraine Drugs Sales by Region (2023-2028) & (K Pcs)
Table 11. Global Migraine Drugs Sales Market Share by Region (2023-2028)
Table 12. Global Migraine Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Migraine Drugs Revenue Market Share by Region (2017-2022)
Table 14. Global Migraine Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Migraine Drugs Revenue Market Share by Region (2023-2028)
Table 16. Global Migraine Drugs Sales by Manufacturers (2017-2022) & (K Pcs)
Table 17. Global Migraine Drugs Sales Share by Manufacturers (2017-2022)
Table 18. Global Migraine Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Migraine Drugs Revenue Share by Manufacturers (2017-2022)
Table 20. Migraine Drugs Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 21. Global Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Migraine Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Drugs as of 2021)
Table 23. Migraine Drugs Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Migraine Drugs Product Offered
Table 25. Date of Manufacturers Enter into Migraine Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Migraine Drugs Sales by Type (2017-2022) & (K Pcs)
Table 28. Global Migraine Drugs Sales by Type (2023-2028) & (K Pcs)
Table 29. Global Migraine Drugs Sales Share by Type (2017-2022)
Table 30. Global Migraine Drugs Sales Share by Type (2023-2028)
Table 31. Global Migraine Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Migraine Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Migraine Drugs Revenue Share by Type (2017-2022)
Table 34. Global Migraine Drugs Revenue Share by Type (2023-2028)
Table 35. Migraine Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 36. Global Migraine Drugs Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 37. Global Migraine Drugs Sales by Application (2017-2022) & (K Pcs)
Table 38. Global Migraine Drugs Sales by Application (2023-2028) & (K Pcs)
Table 39. Global Migraine Drugs Sales Share by Application (2017-2022)
Table 40. Global Migraine Drugs Sales Share by Application (2023-2028)
Table 41. Global Migraine Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Migraine Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Migraine Drugs Revenue Share by Application (2017-2022)
Table 44. Global Migraine Drugs Revenue Share by Application (2023-2028)
Table 45. Migraine Drugs Price by Application (2017-2022) & (USD/Pcs)
Table 46. Global Migraine Drugs Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 47. North America Migraine Drugs Sales by Type (2017-2022) & (K Pcs)
Table 48. North America Migraine Drugs Sales by Type (2023-2028) & (K Pcs)
Table 49. North America Migraine Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Migraine Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Migraine Drugs Sales by Application (2017-2022) & (K Pcs)
Table 52. North America Migraine Drugs Sales by Application (2023-2028) & (K Pcs)
Table 53. North America Migraine Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Migraine Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Migraine Drugs Sales by Country (2017-2022) & (K Pcs)
Table 56. North America Migraine Drugs Sales by Country (2023-2028) & (K Pcs)
Table 57. North America Migraine Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Migraine Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Migraine Drugs Sales by Type (2017-2022) & (K Pcs)
Table 60. Europe Migraine Drugs Sales by Type (2023-2028) & (K Pcs)
Table 61. Europe Migraine Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Migraine Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Migraine Drugs Sales by Application (2017-2022) & (K Pcs)
Table 64. Europe Migraine Drugs Sales by Application (2023-2028) & (K Pcs)
Table 65. Europe Migraine Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Migraine Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Migraine Drugs Sales by Country (2017-2022) & (K Pcs)
Table 68. Europe Migraine Drugs Sales by Country (2023-2028) & (K Pcs)
Table 69. Europe Migraine Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Migraine Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Migraine Drugs Sales by Type (2017-2022) & (K Pcs)
Table 72. Asia Pacific Migraine Drugs Sales by Type (2023-2028) & (K Pcs)
Table 73. Asia Pacific Migraine Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Migraine Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Migraine Drugs Sales by Application (2017-2022) & (K Pcs)
Table 76. Asia Pacific Migraine Drugs Sales by Application (2023-2028) & (K Pcs)
Table 77. Asia Pacific Migraine Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Migraine Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Migraine Drugs Sales by Region (2017-2022) & (K Pcs)
Table 80. Asia Pacific Migraine Drugs Sales by Region (2023-2028) & (K Pcs)
Table 81. Asia Pacific Migraine Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Migraine Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Migraine Drugs Sales by Type (2017-2022) & (K Pcs)
Table 84. Latin America Migraine Drugs Sales by Type (2023-2028) & (K Pcs)
Table 85. Latin America Migraine Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Migraine Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Migraine Drugs Sales by Application (2017-2022) & (K Pcs)
Table 88. Latin America Migraine Drugs Sales by Application (2023-2028) & (K Pcs)
Table 89. Latin America Migraine Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Migraine Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Migraine Drugs Sales by Country (2017-2022) & (K Pcs)
Table 92. Latin America Migraine Drugs Sales by Country (2023-2028) & (K Pcs)
Table 93. Latin America Migraine Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Migraine Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Migraine Drugs Sales by Type (2017-2022) & (K Pcs)
Table 96. Middle East and Africa Migraine Drugs Sales by Type (2023-2028) & (K Pcs)
Table 97. Middle East and Africa Migraine Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Migraine Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Migraine Drugs Sales by Application (2017-2022) & (K Pcs)
Table 100. Middle East and Africa Migraine Drugs Sales by Application (2023-2028) & (K Pcs)
Table 101. Middle East and Africa Migraine Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Migraine Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Migraine Drugs Sales by Country (2017-2022) & (K Pcs)
Table 104. Middle East and Africa Migraine Drugs Sales by Country (2023-2028) & (K Pcs)
Table 105. Middle East and Africa Migraine Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Migraine Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 107. Allergan Corporation Information
Table 108. Allergan Description and Major Businesses
Table 109. Allergan Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. Allergan Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Allergan Recent Developments
Table 112. Merck Corporation Information
Table 113. Merck Description and Major Businesses
Table 114. Merck Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 115. Merck Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Merck Recent Developments
Table 117. Pfizer Corporation Information
Table 118. Pfizer Description and Major Businesses
Table 119. Pfizer Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 120. Pfizer Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Pfizer Recent Developments
Table 122. Teva Corporation Information
Table 123. Teva Description and Major Businesses
Table 124. Teva Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 125. Teva Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Teva Recent Developments
Table 127. Pfizer Corporation Information
Table 128. Pfizer Description and Major Businesses
Table 129. Pfizer Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 130. Pfizer Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Pfizer Recent Developments
Table 132. Johnson & Johnson Corporation Information
Table 133. Johnson & Johnson Description and Major Businesses
Table 134. Johnson & Johnson Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 135. Johnson & Johnson Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Johnson & Johnson Recent Developments
Table 137. Endo International Corporation Information
Table 138. Endo International Description and Major Businesses
Table 139. Endo International Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 140. Endo International Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Endo International Recent Developments
Table 142. GlaxoSmithKline Corporation Information
Table 143. GlaxoSmithKline Description and Major Businesses
Table 144. GlaxoSmithKline Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 145. GlaxoSmithKline Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. GlaxoSmithKline Recent Developments
Table 147. Impax Corporation Information
Table 148. Impax Description and Major Businesses
Table 149. Impax Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 150. Impax Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Impax Recent Developments
Table 152. Abbott Corporation Information
Table 153. Abbott Description and Major Businesses
Table 154. Abbott Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 155. Abbott Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Abbott Recent Developments
Table 157. Bayer Corporation Information
Table 158. Bayer Description and Major Businesses
Table 159. Bayer Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 160. Bayer Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Bayer Recent Developments
Table 162. Eli Lilly Corporation Information
Table 163. Eli Lilly Description and Major Businesses
Table 164. Eli Lilly Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 165. Eli Lilly Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Eli Lilly Recent Developments
Table 167. Ethypharm Corporation Information
Table 168. Ethypharm Description and Major Businesses
Table 169. Ethypharm Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 170. Ethypharm Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Ethypharm Recent Developments
Table 172. Kowa Pharmaceuticals America Corporation Information
Table 173. Kowa Pharmaceuticals America Description and Major Businesses
Table 174. Kowa Pharmaceuticals America Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 175. Kowa Pharmaceuticals America Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Kowa Pharmaceuticals America Recent Developments
Table 177. Winston Pharmaceuticals Corporation Information
Table 178. Winston Pharmaceuticals Description and Major Businesses
Table 179. Winston Pharmaceuticals Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 180. Winston Pharmaceuticals Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Winston Pharmaceuticals Recent Developments
Table 182. AstraZeneca Corporation Information
Table 183. AstraZeneca Description and Major Businesses
Table 184. AstraZeneca Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 185. AstraZeneca Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. AstraZeneca Recent Developments
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Migraine Drugs Distributors List
Table 190. Migraine Drugs Customers List
Table 191. Migraine Drugs Market Trends
Table 192. Migraine Drugs Market Drivers
Table 193. Migraine Drugs Market Challenges
Table 194. Migraine Drugs Market Restraints
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Migraine Drugs Product Picture
Figure 3. Global Migraine Drugs Market Share by Type in 2021 & 2028
Figure 3. Sumatriptan Product Picture
Figure 4. Zolmitriptan Product Picture
Figure 5. Rizatriptan Product Picture
Figure 6. Others Drug Product Picture
Figure 7. Global Migraine Drugs Market Share by Application in 2021 & 2028
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Household Use
Figure 11. Others
Figure 12. Migraine Drugs Report Years Considered
Figure 13. Global Migraine Drugs Sales 2017-2028 (K Pcs)
Figure 14. Global Migraine Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Migraine Drugs Revenue 2017-2028 (US$ Million)
Figure 16. Global Migraine Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Migraine Drugs Sales Market Share by Region (2017-2022)
Figure 18. Global Migraine Drugs Sales Market Share by Region (2023-2028)
Figure 19. North America Migraine Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 20. North America Migraine Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Migraine Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 22. Europe Migraine Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Migraine Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 24. Asia-Pacific Migraine Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Migraine Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 26. Latin America Migraine Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Migraine Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 28. Middle East & Africa Migraine Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Migraine Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Migraine Drugs in the World: Market Share by Migraine Drugs Revenue in 2021
Figure 31. Global Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Migraine Drugs Sales Market Share by Type (2017-2028)
Figure 33. Global Migraine Drugs Revenue Market Share by Type (2017-2028)
Figure 34. Global Migraine Drugs Sales Market Share by Application (2017-2028)
Figure 35. Global Migraine Drugs Revenue Market Share by Application (2017-2028)
Figure 36. North America Migraine Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Migraine Drugs Revenue Market Share by Type (2017-2028)
Figure 38. North America Migraine Drugs Sales Market Share by Application (2017-2028)
Figure 39. North America Migraine Drugs Revenue Market Share by Application (2017-2028)
Figure 40. North America Migraine Drugs Sales Share by Country (2017-2028)
Figure 41. North America Migraine Drugs Revenue Share by Country (2017-2028)
Figure 42. U.S. Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Migraine Drugs Sales Market Share by Type (2017-2028)
Figure 45. Europe Migraine Drugs Revenue Market Share by Type (2017-2028)
Figure 46. Europe Migraine Drugs Sales Market Share by Application (2017-2028)
Figure 47. Europe Migraine Drugs Revenue Market Share by Application (2017-2028)
Figure 48. Europe Migraine Drugs Sales Share by Country (2017-2028)
Figure 49. Europe Migraine Drugs Revenue Share by Country (2017-2028)
Figure 50. Germany Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. France Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Migraine Drugs Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Migraine Drugs Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Migraine Drugs Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Migraine Drugs Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Migraine Drugs Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Migraine Drugs Revenue Share by Region (2017-2028)
Figure 61. China Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. India Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Migraine Drugs Sales Market Share by Type (2017-2028)
Figure 72. Latin America Migraine Drugs Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Migraine Drugs Sales Market Share by Application (2017-2028)
Figure 74. Latin America Migraine Drugs Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Migraine Drugs Sales Share by Country (2017-2028)
Figure 76. Latin America Migraine Drugs Revenue Share by Country (2017-2028)
Figure 77. Mexico Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Migraine Drugs Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Migraine Drugs Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Migraine Drugs Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Migraine Drugs Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Migraine Drugs Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Migraine Drugs Revenue Share by Country (2017-2028)
Figure 86. Turkey Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 88. U.A.E Migraine Drugs Revenue (2017-2028) & (US$ Million)
Figure 89. Migraine Drugs Value Chain
Figure 90. Migraine Drugs Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
